Compare Avantis US Small Cap Value ETF (AVUV) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avantis US Small Cap Value ETF vs Citius Pharmaceuticals Inc — how do they compare? Avantis US Small Cap Value ETF trades at $127.95, while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Avantis US Small Cap Value ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AVUV | CTXR | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $128.74 | $1.82 |
52-Week Low | $93.93 | $0.48 |
Market Cap | — | $20.01M |
Enterprise Value | — | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Avantis US Small Cap Value ETF
AVUV is an actively managed ETF that targets small-cap value companies in the United States. It uses a systematic, rules-based process to identify firms with low valuations and high profitability, aiming to capture the historical premiums of 'size' and 'value' while filtering for financial quality.
Read more on AVUV →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
